About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 407 blog entries.

Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]

2022-09-19T11:05:53+02:00

U. Hasler-Strub, A. Mueller, Q. Li, B. Thuerlimann, K. Ribi, S. Gerber, R. von Moos, M. Fehr, C. Rochlitz, K. Zaman, S. Aebi, A. Hochstrasser, U. Gick, D. Baertschi, S. Greuter, A. Schreiber, C. Caspar, A. Trojan, R. Condorelli, T. Ruhstaller, for the Swiss Group for Clinical Cancer Research (SAKK). Published: September 18, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.09.001

Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]2022-09-19T11:05:53+02:00

Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes

2022-09-12T09:52:42+02:00

Marissa LoCastro, Chandrika Sanapala, Jason H. Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi Klepin, Erin Watson, Jane Liesveld, Eric Huselton, Kristen O'Dwyer, Andrea Baran, Marie Flannery, Benzi M. Kluger, Kah Poh Loh. Published: September 10, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.09.003

Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes2022-09-12T09:52:42+02:00

Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot study

2022-09-14T09:55:23+02:00

Ashley L. Artese, Andrea Sitlinger, Grace MacDonald, Michael A. Deal, Erik D. Hanson, Carl F. Pieper, J. Brice Weinberg, Danielle M. Brander, David B. Bartlett. Published: September 09, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.09.002

Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot study2022-09-14T09:55:23+02:00

Predictive value of the G8 and the IADL-modified G8 screening tools for postoperative delirium following major urological cancer surgery

2022-09-12T09:52:21+02:00

Shugo Yajima, Yasukazu Nakanishi, Rikuto Yasujima, Kouhei Hirose, Ken Sekiya, Yousuke Umino, Naoya Ookubo, Madoka Kataoka, Hitoshi Masuda. Published: August 26, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.08.014

Predictive value of the G8 and the IADL-modified G8 screening tools for postoperative delirium following major urological cancer surgery2022-09-12T09:52:21+02:00

Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer

2022-08-29T14:15:38+02:00

Baran Akagunduz, Deniz Can Guven, Muhammed Ozer, Ilker Nihat Okten, Elif Atag, İlkay Tugba Unek, Ali Murat Tatli, Aziz Karaoglu. Published: August 26, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.08.016

Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer2022-08-29T14:15:38+02:00

What do hematology residents know about caring for older adults with cancer? A National Survey of Canadian hematology residents’ knowledge and interests

2022-08-30T10:49:26+02:00

Victoria David, Tina Hsu, Siraj Mithoowani, Graeme Fraser, Hira Mian. Published: August 29, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.08.018

What do hematology residents know about caring for older adults with cancer? A National Survey of Canadian hematology residents’ knowledge and interests2022-08-30T10:49:26+02:00

Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study

2022-08-29T14:09:17+02:00

Kathleen Van Dyk, Jaeil Ahn, Xingtao Zhou, Wanting Zhai, Tim A. Ahles, Traci N. Bethea, Judith E. Carroll, Harvey Jay Cohen, Asma A. Dilawari, Deena Graham, Paul B. Jacobsen, Heather Jim, Brenna C. McDonald, Zev M. Nakamura, Sunita K. Patel, Kelly E. Rentscher, Andrew J. Saykin, Brent J. Small, Jeanne S. Mandelblatt, James C. Root. Published: August 24, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.08.005

Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study2022-08-29T14:09:17+02:00
Go to Top